Article

Retirement is around the corner for David Karcher, ASCRS executive director

Author(s):

David Karcher, executive director and chief executive officer, The American Society of Cataract and Refractive Surgery (ASCRS), will retire as of December 31, 2018, according to an ASCRS press release. Eric D. Donnenfeld, MD, will chair the search committee responsible for interviewing candidates to fill the role of executive director. Interviews will begin in the late summer or early fall of 2017. Leonard Pfeiffer & Company, a well-known executive search firm, will be assisting in the search.

David Karcher, executive director and chief executive officer, The American Society of Cataract and Refractive Surgery (ASCRS), will retire as of December 31, 2018, according to an ASCRS press release.

Karcher will be a consultant for ASCRS through 2021.

Since August 1981 when he started his leadership role at the organization, membership has grown to more than 8,500, the number of employees has expanded from three to 65, and the annual budget has increased from $360,000 to more than $23 million, the press release said.

“I have been blessed over these many years to work with a dedicated and loyal staff who have been taking direction from a very dynamic and engaged group of volunteer leaders,” Karcher said. “I look forward to watching-from a different vantage point-ASCRS, the ASCRS Foundation, and ASOA continue to grow and prosper.”

Eric D. Donnenfeld, MD, will chair the search committee responsible for interviewing candidates to fill the role of executive director.

Interviews will begin in the late summer or early fall of 2017. Leonard Pfeiffer & Company, a well-known executive search firm, will be assisting in the search. All inquiries should be sent to Zara Sulayman, zrsulayman@pfeiffercompany.com, 202-737-6327, ext 24. 

“There is no one individual who is more responsible for the success of ASCRS than David Karcher,” said Edward J. Holland, MD, chair, ASCRS Program Committee. “Ophthalmologists, administrators and patients worldwide have benefited from Dave’s dedicated work. His honesty, humility, integrity, and outstanding leadership have made our organization exceptional. We will never replace David Karcher, but look to build on the foundation and principles he has instituted for ASCRS.” 

Under Karcher’s leadership, ASCRS restructured its scientific advisory board into clinical committees, which are actively engaged in developing the organization’s annual meeting. The first meeting which was held in 1982 had about 600 registrants, compared with recent registration of upwards of 7,000, the organization said.

ASOA, ASCRS Foundation

 

Karcher also co-founded The American Society of Ophthalmic Administrators (ASOA) in 1985. ASOA is a leading organization for the business side of the ophthalmic practice, providing support, tools, and resources to help ophthalmologists grow, expand, and improve their businesses, the press release said.

Karcher also facilitated development of the ASCRS Foundation, which provides humanitarian support domestically and internationally. Each year in the United States, hundreds of eligible cataract patients who are unable to afford surgery are paired with volunteer surgeons who perform the necessary procedures. In Ethiopia, more than 23,000 patients annually are treated through ASCRS Foundation’s Robert Sinskey Eye Institute in Addis Ababa, the organization said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.